Amendment to Schedule 2B (Criteria to be an eligible arrival)N.I.

9.  In Schedule 2B—

(a)in paragraph 2—

(i)omit sub-paragraph (b);

(ii)after sub-paragraph (d)(ii), insert—

(iia)a North American Certificate;

(iib)a certificate of COVID-19 records issued by an approved third country or territory;;

(iii)in sub-paragraph (d)(iii) omit “or”;

(iv)in sub-paragraph (d)(iv) for “,” substitute “, and”;

(v)omit sub-paragraph (e);

(b)in paragraph 4—

(i)at the end of sub-paragraph (b), insert “and”;

(ii)in sub-paragraph (c) omit “, and”;

(iii)omit sub-paragraph (d);

(c)in paragraph 5—

(i)in sub-paragraph (a) omit “, and”;

(ii)omit sub-paragraph (b);

(d)in paragraph 6—

(i)in the opening words, omit “either”;

(ii)at the end of sub-paragraph (a), omit “, or”;

(iii)omit sub-paragraph (b);

(e)in paragraph 7, after sub-paragraph (a), insert—

(aa)if P has received at least 2 doses of any of the vaccines referred to in sub-paragraph (c) of the definition of “authorised vaccine” in paragraph 10, P is deemed to have completed a course of doses of an authorised vaccine.;

(f)in paragraph 7B, after sub-paragraph (2)(b), insert—

(ba)a North American Certificate;

(bb)a certificate of COVID-19 records issued by an approved third country or territory;;

(g)in paragraph 10—

(i)in the definition of “authorised vaccine”, in sub-paragraph (c), for the words from “would be authorised” to the end, substitute—

(i)would be authorised as provided for in sub-paragraph (a)(i) or (ii) if the doses were received in the United Kingdom, or

(ii)are listed in lines 10, 11 or 13 of the guidance document “Status of COVID-19 Vaccines within WHO EUL/PQ Evaluation Process” published by the World Health Organisation on 11th November 2021(1), and authorised or certified in a regulated country listed in paragraph 12,;

(ii)in the definition of “NHS COVID pass”—

(aa)after “records” insert “available”;

(bb)after “NHS.uk or” insert “in”;

(iii)after the definition of “NHS Wales” insert—

”North American Certificate” means, in relation to a State, District or Province listed in the table in paragraph 10B, the certificate identified in the corresponding row of the second column of that table;;

(h)after paragraph 10, insert—

10A.  The following countries and territories are approved third countries or territories for the purposes of this Schedule—

10B.  The table referred to in the definition of “North American Certificate” in paragraph 10 is—

State, District or ProvenceCertificate Name
New YorkExcelsior Pass Plus
CaliforniaDigital COVID-19 Vaccine Record
Washington StateWA Verify

(i)In paragraph 11, in the opening words, after “paragraph 10” insert “except in the definition of “North American Certificate””;

(j)In paragraph 12, in the list of countries and territories, at the appropriate places insert entries for—

Belarus

Bolivia

British Antarctic Territory

British Indian Ocean Territory

British Virgin Islands

Democratic Republic of Congo

Dominican Republic

Ecuador

Falkland Islands

Guernsey

Isle of Man

Jersey

Laos

Libya

Malawi

Montserrat

Mozambique

Pitcairn, Henderson, Ducie and Oeno Islands

Samoa

Senegal

South Georgia and the South Sandwich Islands

the Soverign Base Areas of Akrotiri and Dhekelia in the Island of Cyprus

St Helena, Ascension and Tristan da Cunha

Turks and Caicos Islands

Vanuatu

Zambia

Zimbabwe.

Commencement Information

I1Reg. 9 in operation at 22.11.2021 at 4.00 a.m., see reg. 1(2)

(1)

A copy may be downloaded from https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_11Nov2021.pdf. A hard copy may be obtained from the Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU